FDA Inspection 1338414 — ABX Advanced Biochemical Compounds Biomedizinische Forschungsreagenzien GmbH
The FDA completed an inspection of ABX Advanced Biochemical Compounds Biomedizinische Forschungsreagenzien GmbH on Jun 13, 2025 in Radeberg. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jun 13, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Radeberg (Germany)
Additional Details
Mutual Recognition Agreement (MRA)